Noubar Afeyan's Moderna aims to make up to 1 billion doses of coronavirus vaccine this year
Moderna Inc, co-founded and headed by American entrepreneur of Armenian descent Noubar Afeyan, is on track to deliver between 600 million and 1 billion doses of its Covid-19 vaccine this year, Chief Executive Stephane Bancel said on Thursday.
Bancel said Moderna had orders for 500 million doses of its vaccine and could comfortably make at least 600 million doses. He told a conference organised by Oddo BHF that the group was working to meet or even exceed a target for 1 billion doses, however, Reuters reported.
Bancel said it was still not clear how long the antibodies generated by the vaccines would last, but added that it could potentially be a couple of years.
Related news
- Noubar Afeyan's Moderna expects its COVID-19 vaccine to protect against UK coronavirus variant
- Anthony Fauci receives Moderna vaccine, has 'extreme confidence' it's safe, effective
- US approves Moderna as second Covid-19 vaccine
- EU agrees coronavirus vaccine deal with Moderna